Vaxart, Inc.
(NASDAQ : VXRT)

( )
VXRT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.06%150.000.0%$678.53m
AMGNAmgen, Inc. -0.35%249.701.5%$585.90m
GILDGilead Sciences, Inc. -1.27%65.181.0%$429.55m
VRTXVertex Pharmaceuticals, Inc. -1.65%294.291.9%$402.50m
REGNRegeneron Pharmaceuticals, Inc. -1.81%624.832.6%$354.90m
ILMNIllumina, Inc. -1.86%209.063.3%$307.20m
SNSSSunesis Pharmaceuticals, Inc. 2.22%4.150.7%$290.10m
NVAXNovavax, Inc. -5.56%37.1875.7%$231.38m
BIIBBiogen, Inc. -0.57%216.341.8%$185.52m
BNTXBioNTech SE -2.91%147.610.0%$150.86m
SAVACassava Sciences, Inc. 2.92%26.470.0%$120.22m
GOVXGeoVax Labs, Inc. -12.83%1.970.0%$104.86m
BMRNBioMarin Pharmaceutical, Inc. -1.98%92.964.2%$97.95m
CRSPCRISPR Therapeutics AG 0.57%72.150.6%$91.12m
EXASEXACT Sciences Corp. -2.73%38.4817.6%$84.05m

Company Profile

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded in 2004 and is headquartered in South San Francisco, CA.